QUANTIFY RESEARCH is a global partner to the pharmaceutical industry in close partnership with academia, patients, public institutions & clinical experts.
Real-world evidence & analytics
Quantify is the leading provider of RWE generated from the world-renouned Nordic data. Through our local presence, expert staff, institutional know-how and more than 10 years’ hands-on experience with the Nordic data, we offer an unparalleled ability to advise and execute Nordic RWE studies with local and global applications. Quantify has a successful track record of advising clients on securing Nordic ethical approval, data access, and optimizing analysis for commercial or regulatory purposes. We also offer RWE services in the EU, UK, and US.
Modelling, Access & Strategy
Quantify is a global provider of health economic evidence and a specialist provider of Nordic market access services including economic models, reimbursement dossiers, and strategic advice. Our experience and expertise ensures an optimized, streamlined market access process across the Nordics. For non-technical stakeholders, Quantify also develops value tools and visualisation dashboards to enhance communication. Our expert staff include ex-payers, ex-pharma, modelling experts, and experienced project managers.
Evidence review & synthesis
Quantify has long standing experience reviewing, interpreting and communicating evidence as part of targeted or systematic literature reviews (SLR). Our team ensures these activities are done systematically, with a focus on usability, to support knowledge management and commercialization activities. QUANTIFY is experienced in summarizing the results of this work through meta-analyses and narrative reviews. Our team consists of 50% PhDs and integrated AI solutions to provide our clients with the very best services.
Press
Anders Gustavsson participates in the Young Leaders Discussion for Innovative Ideas to Address Dementia
Anders Gustavsson of Quantify Research participated in the Young Leaders Discussion for Innovative Ideas to Address Dementia, at the Foreign and Commonwealth Office in London. This event was organised by the UK Science and Innovation Network to support the World Dementia Council in their work. A communique will follow from the meeting.
Paper co-authored by Oskar Ström published in Osteoporosis International
The paper “Residual effect after oral bisphosphonate treatment and healthy adherer effects – the Swedish adherence register analysis (SARA)”, co-authored by Oskar Ström, has been published in Osteoporosis International. The paper investigates the residual effect of oral bisphosphonate treament on fractures. Pubmed link
Quantify Research conducts study adding to the pressure on decision makers to centralise the care and rehabilitation for persons with spinal cord injuries in Sweden.
Quantify Research has conducted a study adding to the pressure on decision makers to centralise the care and rehabilitation for persons with spinal cord injuries in Sweden. The study demonstrates that costs are expected to decrease with centralisation, in addition to improving outcomes for patients. A detailed report is available at the website of The Swedish Association for Survivors of Accident and Injury (RTP), sponsoring the study. One of […]
Healthcare provision and financing in the future?
Yesterday Professor Michael Porter from Harvard Business School gave an inspiring lecture on Value Based Healthcare in Stockholm. In order to reach the ultimate goal of healthcare – increased value (outcomes) for the patients, he sees a need for re-design. Prof. Porter addressed six areas for the strategic agenda. Transformations are required to organize healthcare around the patient, to bundle payments to incorporate the whole care cycle, to specialize […]